Research Fellowships
Research Fellowships Funded by NNPDF
FELLOWSHIP #18
Adam Kanack | Peter G. Pentchev Research Fellowship
The Medical College of Wisconsin
Prevention of NPC1 Ubiquitination as a Therapeutic Target for Niemann-Pick Type C Disease
FELLOWSHIP #17
Ofer Moldavski, PhD| Peter G. Pentchev Research Fellowship
The University of California, Berkley, CA
New Perspective on Niemann-Pick type C Disease as an mTORC1 Dependent Metabolic Disease
FELLOWSHIP #16
Xuntian Jiang, PhD | Peter G. Pentchev Research Fellowship
Washington University, St. Louis, MO
Development of a Diagnostic Test and Newborn Screen for Niemann-Pick C Disease
FELLOWSHIP #15
Andrew Munkacsi, PhD | Peter G. Pentchev Research Bridge Funding
Columbia University Medical Center, New York, NY (Year 1)
Victoria University of Wellington, New Zealand
Defining the Molecular Basis of HDAC Inhibitors to treat Murine, Feline, and Human Models of NPC
FELLOWSHIP #14
Gizely Andrade | Peter G. Pentchev Research Fellowship
Albert Einstein College of Medicine, Bronx, NY
Developing Neurophysiological Outcome Measures for Treatment Assessment in Niemann-Pick type C (NPC) Disease
FELLOWSHIP #13
Xuntian Jiang, PhD | Peter G. Pentchev Research Fellowship
Washington University, St. Louis, MO
Development of a Diagnostic Test and Newborn Screen for Niemann-Pick C Disease
FELLOWSHIP #12
Kanagaraj Subramanian | Peter G. Pentchev Research Fellowship
The Scripps Research Institute, La Jolla, CA
Roadmap for Drug Development for Niemann-Pick Disease
FELLOWSHIP #11
Deepti Gadi, PhD | Peter G. Pentchev Research Fellowship
Weill College of Cornell University, New York, NY
Understanding the cellular mechanism of HDAC inhibitors for the treatment of NPC disease
FELLOWSHIP #10
Stephanie M. Cologna, PhD | Peter G. Pentchev Research Fellowship
National Institute of Health, Bethseda, MD
Differential Protein Expression Profiling in Cerebrospinal Fluid from Niemann-Pick Disease, type C1 Patients
FELLOWSHIP #9
Lluis Samaranch Gusi, PhD | Edward H. Schuchman Fellowship
University of California, San Francisco, CA
AAV9-Mediated Human Acid Sphingomyelinase Expression in Nonhuman Primate Brain: Preclinical Development of Gene Therapy for Niemann-Pick Disease Type A
FELLOWSHIP #8
Andrew Munkacsi, PhD | Peter G. Pentchev Research Bridge Funding
Columbia University Medical Center, New York, NY (Year 1)
Victoria University of Wellington, New Zealand
Defining the Molecular Basis of HDAC Inhibitors to treat Murine, Feline, and Human Models of NPC
FELLOWSHIP #7
Dorothea Maetzel, PhD | Peter G. Pentchev Research Fellowship
Whitehead Institute for Biomedical Research, Cambridge, MA
In Vitro modelling of Niemann-Pick type C Disease Using Patient-Specific Induced Pluripotent Stem Cells
FELLOWSHIP #6
Nicholas Cianciola, PhD | Peter G. Pentchev Research Fellowship
School of Medicine, Case Western Reserve University, Cleveland, OH
Activation of an Alternative Cholesterol Homeostatic Mechanism in NPC
FELLOWSHIP #5
Fabrizio Vacca, PhD | Peter G. Pentchev Research Fellowship
University of Geneva, Switzerland
Analysis of Cholesterol Export from Purified Endosomes in NPC Cellular Models
FELLOWSHIP #4
Ian Williams, PhD | Peter G. Pentchev Research Fellowship
University of Oxford, UK
Neurobiology of Purkinje Cells in NPC1
FELLOWSHIP #3
Nobutaka Ohgami, PhD | Peter G. Pentchev Research Fellowship
Dartmouth Medical School, Hanover, NH
Demonstration of NPC1 as a Lipid Binding Protein in Vitro
FELLOWSHIP #2
Heng-Ling Liou, PhD | Peter G. Pentchev Research Fellowship
University of Medicine & Dentistry of New Jersey -Robert Wood Johnson Medical School, Piscataway, NJ
The Role of NPC2 (Niemann-Pick Disease Type C2) Protein in Lysosomal Cholesterol Trafficking
FELLOWSHIP #1
Amit Kumar Choudhury, PhD | Peter G. Pentchev Research Fellowship
Mayo Clinic and Foundation; Rochester, MN
Reduction of Lipid Accumulation in Niemann-Pick Fibroblasts by Modulation of Membrane Trafficking